MESOTHELIOMA, MALIGNANT
Clinical trials for MESOTHELIOMA, MALIGNANT explained in plain language.
Never miss a new study
Get alerted when new MESOTHELIOMA, MALIGNANT trials appear
Sign up with your email to follow new studies for MESOTHELIOMA, MALIGNANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to boost immune system's fight against aggressive chest cancer
Disease control CompletedThis study tested a two-part treatment plan for people with previously untreated malignant mesothelioma. First, it compared two different low-dose radiation treatments given before surgery. After surgery, eligible patients received a combination of two immunotherapy drugs. The go…
Matched conditions: MESOTHELIOMA, MALIGNANT
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New immune therapy battle against deadly lung lining cancer
Disease control CompletedThis study compared two different first treatments for Chinese patients with advanced mesothelioma, a cancer of the lung lining that cannot be removed by surgery. Researchers tested whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) works better and is sa…
Matched conditions: MESOTHELIOMA, MALIGNANT
Phase: PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC